Lifestance Health Group (LFST)
NASDAQ:LFST
Want to see LFST full AI Analyst Report?
LFST Stock Chart & Stats
$6.89
$0.15(1.99%)
At close: 4:00 PM EST
$6.89
$0.15(1.99%)
Day’s Range― - ―
52-Week Range$3.74 - $8.09
Previous CloseN/A
Volume196.56K
Average Volume (3M)1.80M
Market Cap
$2.85B
Enterprise Value$2.80B
Total Cash (Recent Filing)$248.64M
Total Debt (Recent Filing)$194.10M
Price to Earnings (P/E)58.2
Beta0.62
Next Earnings
Aug 12, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding387,827,670
10 Day Avg. Volume1,528,730
30 Day Avg. Volume1,802,244
Financial Highlights & Ratios
PEG Ratio-2.34
Price to Book (P/B)1.79
Price to Sales (P/S)1.91
P/FCF Ratio24.70
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue1.97
Enterprise Value/Gross Profit6.46
Enterprise Value/Ebitda35.54
Forecast
1Y Price Target
$9.57Price Target Upside38.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)0.07
Revenue Forecast (FY)$1.64B
Bulls Say, Bears Say
Bulls Say
Financial Performance And Capital AllocationResults that exceeded analyst expectations supported stronger free cash flow, enabling a share buyback and management guidance above consensus that signals confidence in growth.
Patient Matching And RetentionThe care‑matching platform increases conversion of prospective patients into first visits by pairing them with the right clinician, which can boost retention and stabilize revenue.
Technology And AI AdoptionAdoption of AI-driven tools and automation reduces manual clinician tasks and administrative variability, lowering clinician support costs and improving operating margins.
Bears Say
Cost Structure PressureHigh clinician compensation and real estate occupancy are significant expense drivers that could compress margins if cost control measures are insufficient.
EHR Transition Execution RiskSwitching electronic health record vendors creates execution risk that could disrupt AI integrations and slow planned operational improvements.
Reliance On Clinician Productivity And ReimbursementSustaining fuller clinician schedules and favorable reimbursement is critical; failure to maintain productivity or endure rate cuts could weaken revenue momentum.
Lifestance Health Group News
LFST FAQ
What was Lifestance Health Group’s price range in the past 12 months?
Lifestance Health Group lowest stock price was $3.74 and its highest was $8.09 in the past 12 months.
What is Lifestance Health Group’s market cap?
Lifestance Health Group’s market cap is $2.85B.
When is Lifestance Health Group’s upcoming earnings report date?
Lifestance Health Group’s upcoming earnings report date is Aug 12, 2026 which is in 97 days.
How were Lifestance Health Group’s earnings last quarter?
Lifestance Health Group released its earnings results on May 07, 2026. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.007 by $0.033.
Is Lifestance Health Group overvalued?
According to Wall Street analysts Lifestance Health Group’s price is currently Undervalued.
Does Lifestance Health Group pay dividends?
Lifestance Health Group does not currently pay dividends.
What is Lifestance Health Group’s EPS estimate?
Lifestance Health Group’s EPS estimate is 0.01.
How many shares outstanding does Lifestance Health Group have?
Lifestance Health Group has 387,827,670 shares outstanding.
What happened to Lifestance Health Group’s price movement after its last earnings report?
Lifestance Health Group reported an EPS of $0.04 in its last earnings report, beating expectations of $0.007. Following the earnings report the stock price went up 3.782%.
Which hedge fund is a major shareholder of Lifestance Health Group?
Currently, no hedge funds are holding shares in LFST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lifestance Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.57 (38.92% Upside)
$9.57 (38.92% Upside)
Blogger Sentiment
Bullish
LFST Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 1.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $175.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 13.7%
Last 30 Days ▲ 13.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.83%
12-Months-Change
Fundamentals
Return on Equity
0.65%
Trailing 12-Months
Asset Growth
4.02%
Trailing 12-Months
Company Description
Lifestance Health Group
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
LFST Company Deck
LFST Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights substantial progress in 2025: double-digit revenue and visit growth, clinician base expansion, meaningful productivity gains, record adjusted EBITDA margins, positive net income achieved early, strong free cash flow, and disciplined technology investments (including AI) driving operational improvements. Management provided constructive 2026 guidance with continued revenue and margin expansion and capital allocation optionality (share repurchase, disciplined M&A). The main headwinds are implementation costs and execution risk for a new EHR, ongoing competitive pressure for clinicians, a sizable stock-based compensation run rate in 2026, flat revenue per visit in the latest quarter, and the initial lower-margin impact of new center openings. Overall, the positive operational and financial momentum and clear path to margin expansion outweigh the manageable execution and market risks discussed.View all LFST earnings summariesLFST Stock 12 Month Forecast
Average Price Target
$9.57
▲(38.92% Upside)
Technical Analysis
Acadia Healthcare
―
Brookdale Senior Living
―
National Healthcare
―
Select Medical
―
Aveanna Healthcare Holdings
―
Ownership Overview
60.16% Insiders
19.23% Mutual Funds
3.14% Other Institutional Investors
4.83% Public Companies and
Individual Investors